1 / 52

A Tissue Engineered Bioactive Vascular Scaffold

A Tissue Engineered Bioactive Vascular Scaffold. Karen Roberts – Biomedical Engineering Janell Carter – Biomedical Engineering Dr. Kenneth Barbee – Advisor Senior Design Final Presentation May 24, 2001. Objective. The broad objective is to develop a bioactive vascular scaffold

derick
Télécharger la présentation

A Tissue Engineered Bioactive Vascular Scaffold

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A Tissue Engineered Bioactive Vascular Scaffold Karen Roberts – Biomedical Engineering Janell Carter – Biomedical Engineering Dr. Kenneth Barbee – Advisor Senior Design Final Presentation May 24, 2001

  2. Objective The broad objective is to develop a bioactive vascular scaffold Specific Scaffold Geometry Mechanical Conditioning Dynamic Culturing

  3. Proposed Tissue Engineered Artery A tissue engineered biodegradable PLAGA electrospun cylindrical scaffold seeded with smooth muscle cells The electrospun scaffold will provide a porous environment for cell invasion The mechanical properties will be enhanced with dynamic mechanical conditioning

  4. Significance Solutions Available Our Proposed Idea Electrospinning Dynamic Mechanical Conditioning Phase I Phase II Results Problems Encounted Future Investigations – Phase III References Agenda

  5. Significance Cardio vascular disease is principle killer in US About 58 million American (almost one-fourth of the nations population) live with some form of cardiovascular disease • High blood pressure - 50,000,000 • Coronary heart disease - 12,200,000 Small Artery Graft procedures - 600,000/ yr

  6. Solutions Available • Angioplasty • Balloon catheter • Stent • Small mesh like wire tube • 95% successful • 20-25% experience restenosis • Bypass • Segment of vein, usually from leg, to by pass blockage.

  7. Implants & Solution In Development • Endothelial Cell Repair • Endothelial cell / polymer matrix scaffold • Help fight restenosis • Collateral angiogenesis • Burning tiny holes into heart for vessel growth • Hormone therapy

  8. Pseudo Tissue Engineered Arteries • Plastic tube surgically placed in abdominal cavity • Fibrous tissue growth • Tube removed, tissue tube used for bypass • Animal studies have lasted 12 months

  9. Background Ideally – Tissue engineering is to develop a material that is biologically functional Synthetic material results in heightened immune response Bioabsorbable scaffold would guide cells to a specific geometry and degrade as the cells proliferate

  10. Anatomy Tunica Intima Elastic = Mixed = Muscular Tunica Media • Elastic: greater elastin-collagen content • Mixed: Equal SMC and elastin-collagen content • Muscular: greater SMC content Tunica Adventia Elastic = Mixed = Muscular

  11. Anatomy – Tunica Media • The number of concentric layers is proportional to wall thickness Aorta – Thin Wall relative to internal diameter Coronary – Thick walled relative to diameter • Surrounding elastic lamina is less defined in comparison with the internal lamina

  12. Mechanical Properties • Visco-elastic Stress-Strain Curve • Two moduli shows both properties • Coronary arteries are in most demand • Physiological pressures • Systolic 120 mmHg • Diastolic 90 mmHg

  13. Dynamic Mechanical Conditioning Repetitive mechanical conditioning in the form of cyclic stress Inflation and deflation of silicone conduits in a bioreactor by filling with cell culturing medium This is hypothesized to increase cell growth, proliferation, and enhance organization – As a result mechanical properties will be enhanced Studies by Seliktar et al. have had moderate success

  14. Dynamic Mechanical Conditioning

  15. PLAGA Components – Lactic Acid and Glycolic Acid Glycolic acid is naturally occurring in fruit acid derived from sugar cane Lactic acid is a naturally occurring substance found in body They form a copolymer when polymerized Dexon was first FDA approved totally synthetic absorbable suture

  16. PLAGA Copolymer degrades by hydrolysis Macrophages easily consume these particles Mechanical properties can be altered by changing the concentrations and chain lengths Homopolymer combinations are more crystalline Copolymers are more amorphous

  17. Electrospinning A nonwoven porous mesh can be fabricated by electrospinning The electrospinning process employs the use of electrostatic fields to form and accelerate liquid jets from the tip of a capillary Evaporation of the solvent forms fibers that are nanometers in diameter The resultant nonwoven mesh is of variable fiber diameters and pore size distribution

  18. Electrospinning

  19. Tensile test Young’s modulus % Elongation Toughness Ultimate strength Porosity Average Pore Size SEM Mat thickness Porosity Fiber diameter Matrix Characterization

  20. Mechanical Testing Used to determine the stress/ strain data under tension, compression, and torsion Nanofiber matrices - tensile test are conducted because the primary force arteries are subjected to in vivo are radial tensile forces There is an acceptable amount of error associated with this data

  21. Specific Aims – Phase I Electrospin a variety of mats in accordance to our design matrix Fully characterize the mats by performing mechanical and porosity tests

  22. Specific Aims – Phase II Electrospin PLAGA scaffold on to a mandrel of characteristic artery shape according to results from phase I Conduct characterization by SEM

  23. Specific Aims – Phase III Sterilization of scaffolds Seed smooth muscle cells on to cylindrical scaffold Dynamically culture cells and mechanically condition scaffold. PLAGA degredation studies

  24. Goals Achieved Phase I: 20 wt% PLAGA Planar Mat Phase II: Cylindrical PLAGA Scaffolds 15 wt % - 20 wt% - 25 wt% 20 wt% - 25 wt% layered

  25. Preliminary Study Procedure Electrospun mat from 20 wt % PLAGA in 80:20 THF/DMF solution Characterization • Tensile testing – 1x6 cm strips • SEM – 1cm2 gold sputtered • Porosity – Mercury fills pores for density readings

  26. Secondary Study Procedure The primary goal of this study was to achieve a variety electrospun 50:50 PLAGA scaffold in a tubular shape • 15 wt% • 20 wt% • 25 wt% • Layered 20 & 25 wt% Characterization of cylindrical scaffold • SEM – 1cm2 gold sputtered

  27. Electrospinning Chamber

  28. Rotation Device Polymer solution Grounded aluminum mandrel Grounded aluminum mandrel Positive needle Silicone mandrel

  29. Construct Aluminum Mandrel Silicone Sleeve A silicone sleeve slid over a grounded aluminum mandrel The construct was attached to a gearbox with a motor Construct was rotated at a gear ratio of 807.93:1 PLAGA Construct

  30. Results Preliminary Study: • 20 wt% PLAGA Planar Mat

  31. Tensile Test 20 wt% PLAGA Mat

  32. Tensile Test 20 wt% PLAGA Mat

  33. Porosity 20 wt% Mat

  34. 20 wt% PLAGA Planar Mat Fiber Diameter: 170 nm – 10 mm Pore Size: 1-100 mm

  35. Results Secondary Study: Cylindrical PLAGA Scaffolds • 15 wt % • 20 wt% • 25 wt% • 20 wt% - 25 wt% layered

  36. 15 wt% PLAGA Cross Section Thickness: 241mm Fiber Diameter: None Pore size None

  37. 20 wt % PLAGA Cross Section Thickness: 15 mm Fiber Diameter: 170 nm Pore Size: 1 – 5 mm

  38. 25 wt % PLAGA Cross Section Thickness: 60 mm Fiber Diameter: 1-10 mm Pore Size: 10 – 50 mm

  39. 25 wt% PLAGA Cross Section Thickness: 60 mm Fiber Diameter: 1-10 mm Pore Size: 10 – 50 mm

  40. 25 wt % PLAGA Lateral View Thickness: 60 mm Fiber Diameter: 1-10 mm Pore Size: 10 – 50 mm

  41. 20 wt% & 25 wt% PLAGA Layered Lateral View Thickness Total: 108 mm Thickness Each Layer: 34 mm 38 mm 34 mm 36 mm

  42. 20 wt% & 25 wt% PLAGA Layered Cross Section Thickness Total: 108 mm Thickness Each Layer: 34 mm 38 mm 34 mm 36 mm

  43. 20 wt% & 25 wt% PLAGA Layered

  44. Phase I & II– Humidity/Rain – Properties of Electrospun PLAGA was compromised in these conditions i.e. melting Phase III – Sterilization – All forms of sterilization melted the PLAGA except UV radiation & ethylene oxide UV radiation – Did not completely sterilize all of the time Money – dynamic culturing apparatus upwards of $40K Problems Encountered

  45. Future Investigations – Phase III The scaffold that we designed was for use with Dynatek Dalta SVP216 - Small Vascular Prosthesis Tester This would provide the environment for dynamic mechanical conditioning of the cell seeded scaffold while maintaining an environment that is suitable for cell growth & proliferation

  46. Cell Culturing Seeding cells and incubate for 2 days using standard cell culturing techniques This is to allow for cell adhesion to PLAGA Dynamically condition / culturing for 4 – 8 additional days

  47. SVP216 - Small Vascular Prosthesis Tester Produce data acceptable to the FDA Positive displacement pumping system ensures known geometric expansion of samples All samples submersible in 37 degree C bath 2mm-16mm inner diameter grafts

  48. Latex and Silicone Precision Mock Arteries Known mechanical properties leaves no second guessing Get the exact fit with precision diameters Fit all your products with virtually any shape or size

  49. Considerations for the Future Mechanical conditioning must maintaining the correct mechanical properties – Smooth muscle cells will rearrange within the scaffold as mechanical conditioning occurs Liquid Chromatography / Mass Spectroscopy monitoring of degradation of the polymer matrix over time A variety of PLAGA mixtures such as 85:15 or 90:10

  50. Dr. Kenneth Barbee Dr. Frank Ko Dr. Attawia Yusef Khan – Porosity Asaf Ali – Mechanical Testing Dave Rohr – SEM Special Thanks

More Related